The Colorado Department of Public Health and Environment (CDPHE) has confirmed a case of clade I mpox in a resident of the Denver metro area. Officials are encouraging people in higher-risk groups to get vaccinated.
Clade I is one of the two main types of the mpox virus, formerly known as monkeypox. According to CDPHE, health officials are tracking it closely because it only recently began spreading in the United States. Clade II was responsible for the global outbreak that began in 2022 and is still ongoing.
Data from the Centers for Disease Control and Prevention (CDC) show that more than 200 clade I cases were recorded in the U.S. in October, in at least 31 states and Puerto Rico. Information shared by the media indicates that some of the infections most likely occurred in the U.S., with no known link to international travel. No deaths have been reported. According to KDVR, the CDPHE website lists 46 mpox cases in Colorado so far in 2026.
CDPHE notes that clade I has historically been considered more severe than clade II. Dr. Rachel Herlihy, the state epidemiologist, said the risk to the general population remains very low. She added that people at increased risk should consider getting vaccinated.
The Jynneos vaccine protects against both clades. People who have had contact with a person who is ill should, if possible, get vaccinated within four days of exposure. Symptoms of mpox include a rash or blister-like lesions, fever, chills, and headaches and muscle aches.
CDPHE recommends that people with a new rash or skin lesions who may have been exposed to the virus get tested for mpox. This also applies to people who have been vaccinated or who have had the disease before. Officials did not disclose the identity of the patient.
Source: Denver Post
KN

